FDA approves cancer drug based on clinical trial led by researcher at UB, Roswell Park
March 31, 2026
March 31, 2026
BUFFALO, New York, March 31 -- The University at Buffalo (State University of New York) posted the following news release:
* * *
FDA approves cancer drug based on clinical trial led by researcher at UB, Roswell Park
By Ellen Goldbaum
BUFFALO, N.Y. - The Food and Drug Administration has approved the immune checkpoint inhibitor nivolumab in combination with chemotherapy for adults and adolescents 12 and older with previously untreated Stage III/I . . .
* * *
FDA approves cancer drug based on clinical trial led by researcher at UB, Roswell Park
By Ellen Goldbaum
BUFFALO, N.Y. - The Food and Drug Administration has approved the immune checkpoint inhibitor nivolumab in combination with chemotherapy for adults and adolescents 12 and older with previously untreated Stage III/I . . .